Sudarshan Pharma Industries Ltd Registered Office: 301 3rd Floor Aura Biplex,SV Road Borivali(West), Mumbai - 400092, Maharashtra, India. Phone : 91-22-42221111 Fax: Email : compliance.spil@gmail.com Website :www.sudarshanpharma.com Public issue of 68,62,400 equity shares of face value of Rs. 10.00 each ("Equity Shares") of Sudarshan Pharma Industries Limited (the "Company" or the "Issuer") for cash at a price of Rs. 73.00 per equity share including a share premium of Rs. 63.00 per equity share (the "Issue Price") aggregating to Rs. 50.10 crores ("The Issue") of which 3,44,000 equity shares aggregating to Rs. 2.51 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 65,18,400 equity shares aggregating to Rs. 47.59 crores (the "Net Issue"). The issue and the net issue will constitute 28.52% and 27.09% respectively of the post issue paid-up equity share capital of the company. Issue Price : Rs. 73 per equity share of face value of Rs. 10 each. Anchor Investor Issue Price : Rs. 73 per equity shares The issue price is 7.3 times of the face value. Bids can be made for a minimum of 1600 equity shares and in multiples of 1600 equity shares thereafter. Issue Opens On Closes On 09-Mar-23 14-Mar-23 Money Payable On Application Allotment 73.00 0.00 Minimum Application for shares in Nos : 1600 Further Multiples of : 1600 Cr Lead Managers to the Issue Project Cost (.Cr) 42.20 Gretex Corporate Services Ltd Project Financed through Current Offer (.Cr) 50.10 Post Issue Equity Share Capital (.Cr) 24.07 Issue Price () 73.00 Projects Working Capital Requirements General Corporate Purposes Promoted By Hemal Vasantrai Mehta Sachin Vasantrai Mehta Listing At BSE - SME Registrar to the Issue No Data Available